Opioid Substitution to Improve the Effectiveness of Chronic Noncancer Pain Control: A Chart Review

We evaluated the efficacy and tolerability of opioids in the long-term management of chronic noncancer pain. This retrospective chart review included 86 outpatients who started receiving, between 1994 and 1998, long-acting opioids. For each patient, the number of different opioids used and the efficacy and tolerability of each opioid prescribed were noted. During a mean follow-up of 8.8 ± 6.3 mo, the number of opioids used by each patient was 2.3 ± 1.4. Patient diagnoses were: back pain (31), neuropathy (20), joint pain (13), visceral pain (7), reflex sympathetic dystrophy (7), headache (5), fibromyalgia (3). The first opioid prescribed was effective for 36% of patients, was stopped because of side effects in 30%, and was stopped for ineffectiveness in 34%. Of the remaining patients, the second opioid prescribed after the failure of the first was effective in 31%, the third in 40%, the fourth in 56%, and the fifth in 14%. There was one case of addiction and no case of tolerance. We conclude that if it is necessary to change the opioid prescription because of intolerable side effects or ineffectiveness, the cumulative percentage of efficacy increases with each new opioid tested. Failure of one opioid cannot predict the patient’s response to another. Implications: This study showed that if a patient receiving chronic opioid therapy experiences an intolerable side effect or if the drug is ineffective, changing to a different opioid may result in a lessening or elimination of the side effect and/or improved analgesia.

[1]  S. Wessely,et al.  Medication misuse, abuse and dependence in chronic pain patients. , 1997, Journal of psychosomatic research.

[2]  E. Kharasch,et al.  Fentanyl metabolism by human hepatic and intestinal cytochrome P450 3A4: implications for interindividual variability in disposition, efficacy, and drug interactions. , 1997, Drug metabolism and disposition: the biological fate of chemicals.

[3]  C. Stein.  Opioid Treatment of Chronic Nonmalignant Pain1 , 1997, Anesthesia and analgesia.

[4]  D. Jasinski.  Tolerance and dependence to opiates , 1997, Acta anaesthesiologica Scandinavica.

[5]  L. Christrup.  Morphine metabolites , 1997, Acta anaesthesiologica Scandinavica.

[6]  S. Savage.  Long-term opioid therapy: assessment of consequences and risks. , 1996, Journal of pain and symptom management.

[7]  R. Portenoy,et al.  Opioid therapy for chronic nonmalignant pain: a review of the critical issues. , 1996, Journal of pain and symptom management.

[8]  H. Merskey,et al.  Randomised trial of oral morphine for chronic non-cancer pain , 1996, The Lancet.

[9]  N. Cherny.  Opioid analgesics: comparative features and prescribing guidelines. , 1996, Drugs.

[10]  H. Markley.  Chronic headache: Appropriate use of opiate analgesics , 1994, Neurology.

[11]  D. Ziegler,et al.  Opiate and Opioid Use in Patients With Refractory Headache , 1994, Cephalalgia : an international journal of headache.

[12]  A. Dickenson.  Neurophysiology of opioid poorly responsive pain. , 1994, Cancer surveys.

[13]  D. Denson,et al.  Clinical efficacy of methadone in patients refractory to other μ‐opioid receptor agonist analgesics for management of terminal cancer pain. Case presentations and discussion of incomplete cross‐tolerance among opioid agonist analgesics , 1993, Cancer.

[14]  T. Yaksh,et al.  Suppression of nociceptive responses by spinal mu opioid agonists: effects of stimulus intensity and agonist efficacy. , 1993, Anesthesia and analgesia.

[15]  P. Masand,et al.  Chronic Nonmalignant Pain Treated with Long-Term Oral Narcotic Analgesics , 1992 .

[16]  A. Jadad,et al.  Morphine responsiveness of chronic pain: double-blind randomised crossover study with patient-controlled analgesia , 1992, The Lancet.

[17]  G. Pasternak,et al.  Individual variability in the response to different opioids: report of five cases , 1992, Pain.

[18]  M Tryba,et al.  Long-term oral opioid therapy in patients with chronic nonmalignant pain. , 1992, Journal of pain and symptom management.

[19]  G. Pasternak,et al.  Genetic influences in opioid analgesic sensitivity in mice , 1991, Brain Research.

[20]  R. Portenoy,et al.  The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusions , 1990, Pain.

[21]  T. Yaksh,et al.  Differential cross-tolerance between intrathecal morphine and sufentanil in the rat. , 1990, Anesthesiology.

[22]  M. Cousins,et al.  A comparative study of the efficacy and pharmacokinetics of oral methadone and morphine in the treatment of severe pain in patients with cancer , 1986, Pain.

[23]  Russell K. Portenoy,et al.  Chronic use of opioid analgesics in non-malignant pain: Report of 38 cases , 1986, Pain.

[24]  H. Jick,et al.  Addiction rare in patients treated with narcotics. , 1980, The New England journal of medicine.